patent/CN-104394878-A

http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104394878-A

Outgoing Links

Predicate	Object
assignee	http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f905c88c81a7de85531801a97f5f0739
classificationCPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-085 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4178 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
classificationIPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-381 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4178 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-166 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-43 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
filingDate	2013-02-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor	http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_665b5756b3436f70fa8fd60b9aaf7f07
publicationDate	2015-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber	CN-104394878-A
titleOfInvention	Compositions and methods for treating peripheral vascular disease
abstract	The present invention relates to compositions and methods for treating peripheral vascular disease (PVD). In particular, the present invention provides angiotensin (1-7) receptor agonists, ACE2 and/or ACE2 activators based on the use of angiotensin (1-7) peptides or functional equivalents, analogs or derivatives thereof Compositions and methods for treating critical limb ischemia and related diseases, disorders or conditions.
isCitedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112626099-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114703215-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111612860-B http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111612860-A
priorityDate	2012-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type	http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate	Subject
isCitedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6177407-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-100525830-C
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID428562208 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID75067569

Total number of triples: 37.